Net shares · 90d
-13.2K
0 buy · 13.2K sell
Net value · 90d
-$2.7M
$0 in · $2.7M out
Sentiment · 90d
Net selling
0% buying · 100% selling
Open-market trades · 90d
17
0 buy · 13.2K sell
Net buy / sell volume (all companies)
Not enough data to chart yet.
Tap or hover the chart for daily net volume. Green = net buying, red = net selling.
All transactions · open-market
Include grants & non-market-
NTRA Sell·S
PRESIDENT, CLINICALDIAGNOSTICS · 10b5-1
$126.2K
572 sh · $220.67
Own -0%
-
NTRA Sell·S
PRESIDENT, CLINICALDIAGNOSTICS · 10b5-1
$46.7K
213 sh · $219.34
Own -0%
-
NTRA Sell·S
PRESIDENT, CLINICALDIAGNOSTICS · 10b5-1
$90.4K
413 sh · $218.84
Own -0%
-
NTRA Sell·S
PRESIDENT, CLINICALDIAGNOSTICS · 10b5-1
$392.0K
1.8K sh · $217.52
Own -1%
-
NTRA Sell·S
PRESIDENT, CLINICALDIAGNOSTICS · 10b5-1
$335.1K
1.7K sh · $202.84
Own -1%
-
NTRA Sell·S
PRESIDENT, CLINICALDIAGNOSTICS · 10b5-1
$31.0K
150 sh · $206.93
Own -0%
-
NTRA Sell·S
PRESIDENT, CLINICALDIAGNOSTICS · 10b5-1
$82.1K
400 sh · $205.31
Own -0%
-
NTRA Sell·S
PRESIDENT, CLINICALDIAGNOSTICS · 10b5-1
$176.9K
865 sh · $204.47
Own -1%
-
NTRA Sell·S
PRESIDENT, CLINICALDIAGNOSTICS · 10b5-1
$102.7K
505 sh · $203.32
Own -0%
-
NTRA Sell·S
PRESIDENT, CLINICALDIAGNOSTICS · 10b5-1
$104.8K
520 sh · $201.60
Own -0%
-
NTRA Sell·S
PRESIDENT, CLINICALDIAGNOSTICS · 10b5-1
$112.5K
560 sh · $200.95
Own -0%
-
NTRA Sell·S
PRESIDENT, CLINICALDIAGNOSTICS · 10b5-1
$83.5K
405 sh · $206.16
Own -0%
-
NTRA Sell·S
PRESIDENT, CLINICALDIAGNOSTICS · 10b5-1
$242.2K
1.2K sh · $204.39
Own -1%
-
NTRA Sell·S
PRESIDENT, CLINICALDIAGNOSTICS · 10b5-1
$203.1K
997 sh · $203.75
Own -1%
-
NTRA Sell·S
PRESIDENT, CLINICALDIAGNOSTICS · 10b5-1
$193.6K
952 sh · $203.31
Own -1%
-
NTRA Sell·S
PRESIDENT, CLINICALDIAGNOSTICS · 10b5-1
$202.4K
1.0K sh · $202.36
Own -1%
-
NTRA Sell·S
PRESIDENT, CLINICALDIAGNOSTICS · 10b5-1
$211.0K
1.0K sh · $201.32
Own -1%
| Date▾ | Ticker | Type | Shares | Value |
|---|---|---|---|---|
| Jun 1, 2026 | NTRA | Sell S | 572 | $126.2K |
| Jun 1, 2026 | NTRA | Sell S | 213 | $46.7K |
| Jun 1, 2026 | NTRA | Sell S | 413 | $90.4K |
| Jun 1, 2026 | NTRA | Sell S | 1.8K | $392.0K |
| May 26, 2026 | NTRA | Sell S | 1.7K | $335.1K |
| May 1, 2026 | NTRA | Sell S | 150 | $31.0K |
| May 1, 2026 | NTRA | Sell S | 400 | $82.1K |
| May 1, 2026 | NTRA | Sell S | 865 | $176.9K |
| May 1, 2026 | NTRA | Sell S | 505 | $102.7K |
| May 1, 2026 | NTRA | Sell S | 520 | $104.8K |
| May 1, 2026 | NTRA | Sell S | 560 | $112.5K |
| May 1, 2026 | NTRA | Sell S | 405 | $83.5K |
| Apr 27, 2026 | NTRA | Sell S | 1.2K | $242.2K |
| Apr 27, 2026 | NTRA | Sell S | 997 | $203.1K |
| Apr 1, 2026 | NTRA | Sell S | 952 | $193.6K |
| Apr 1, 2026 | NTRA | Sell S | 1.0K | $202.4K |
| Apr 1, 2026 | NTRA | Sell S | 1.0K | $211.0K |
About Solomon Moshkevich
This profile aggregates every SEC Form 4 insider transaction reported by Solomon Moshkevich across all companies they trade. Open-market purchases (code P) and sales (code S) are the highest-signal, discretionary trades; grants (A), option exercises (M) and gifts (G) reflect compensation rather than conviction and carry no market price. Figures cover the selected period and update as new filings are ingested.